Who founded Lavo Life Sciences?

Lavo Life Sciences was founded by Scott Swarthout, Zach Glick, Derek Metcalf in 2022.

Who are Lavo Life Sciences's investors?

Lavo Life Sciences's investors include Eastlink Capital Partners, Undeterred Capital, Y Combinator, BBQ Capital, Peterson Venture Partners.

Lavo Life Sciences

DefunctYC W23

Founded 2022 · 3 employees · 5 known investors

Find your way into Lavo Life Sciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the Lavo Life Sciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Lavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.

AI & Machine Learning Biotech Healthtech AI-powered Drug Discovery Machine Learning Drug discovery

Founders & leadership· Y Combinator alumni (W23)

Lavo Life Sciences was founded in 2022 by Scott Swarthout, Zach Glick, and Derek Metcalf.

Scott Swarthout CEO, Co-Founder (Acquired by Dayhoff Labs)2022–2025Scott Swarthout is the founder and CEO of Lavo Life Sciences, which provides computational molecular simulation services to pharmaceutical companies.

Zach GlickCTO, Co-founder2023–2025

Derek Metcalf Chief Science Officer, Cofounder

Investors · 5

Eastlink Capital Partnerslisted by Eastlink Capital PartnersMenlo Park · $100K – $5M

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Undeterred Capitallisted by Undeterred CapitalLos Angeles · $500K – $1Mvia Joe Wilson · inferred

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

BBQ CapitalreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Peterson Venture PartnersreportedSalt Lake City · $5M – $25M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

Harmonic DiscoveryHarmonic Discovery applies medicinal chemistry, cheminformatics, data science and machine learning expertise to advance drug discovery. The company is supported by investors at the intersection of technology, biology and medicine.

Paceline BioPlay Health builds a clinical decision-support platform for healthcare providers to deliver personalized menopause and women's health care. The platform serves primary care physicians and other providers treating women navigating perimenopause and menopause.

Numerion LabsNumerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.

Ångström AIÅngström AI develops AI-powered physics simulations for pharmaceutical drug discovery, computing molecular properties like solubility, lipophilicity, and crystal structure stability to replace traditional lab experiments. The platform uses machine learning interatomic potentials and free energy calculations to accelerate and derisk solid form development for pharma companies.

Atlas DiscoveryAtlasDiscovery develops foundation models of patient drug response trained on pre-clinical and clinical data to improve drug trial design and success rates. The company serves pharmaceutical and biotech firms by predicting human drug responses and enabling drug rescue and development in the biotech industry.

Companies working in the same space as Lavo Life Sciences.

Legal entities · 1

corporate structure

Lavo Life Sciences Inc.

In the news

⚛️ Lavo Life Sciences - Computer simulations of drug moleculesycombinator.com · Feb 2023

Frequently asked questions

What does Lavo Life Sciences do?: Lavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.
Who founded Lavo Life Sciences?: Lavo Life Sciences was founded by Scott Swarthout, Zach Glick, Derek Metcalf in 2022.
Who are Lavo Life Sciences's investors?: Lavo Life Sciences's investors include Eastlink Capital Partners, Undeterred Capital, Y Combinator, BBQ Capital, Peterson Venture Partners.